Scientists at Oregon Health & Science University, Stanford University, University of Valencia and IGENOMIX have discovered that chromosomal abnormalities in human embryos created for in vitro fertilization, or IVF, can be predicted within the first 30 hours of development at the cell-1 stage which results from the union of a female egg and male sperm.
Oregon Health & Science University today announced it met Nike co-founder Phil Knight and his wife Penny’s $1 billion challenge by raising $500 million in less than two years to earn the Knights’ matching gift and set a fundraising record.
In celebration of the collective strength, character and creativity of its patients, OHSU Doernbecher Children’s Hospital today announced the patient-designers of the 12th-annual Nike “Doernbecher Freestyle” program
Advancing the field of structural biology that underpins how things work in a cell, researchers have identified how proteins change their shape when performing specific functions.
The OHSU Knight Cardiovascular Institute has been awarded the Get With The Guidelines®–Heart Failure Gold-Plus Quality Achievement Award from the American Heart Association/American College of Cardiology Foundation for consistently meeting advanced quality of care measures for the diagnosis and treatment of patients with heart failure.
Oregon Health & Science University, in partnership with Silicon Valley startup Vynca, Oregon POLST and the Oregon POLST Registry, today announced the launch of ePOLST, a fully integrated electronic version of the Physician Orders for Life-Sustaining Treatment, commonly known as POLST, which will assist health care systems in more accurately recording and accessing the wishes of patients who are nearing the end of life.